Stroke krónikus veseelégtelenségben

Translated title of the contribution: Stroke in chronic renal failure

Research output: Contribution to journalArticle

Abstract

Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.

Original languageHungarian
Pages (from-to)691-696
Number of pages6
JournalOrvosi Hetilap
Volume149
Issue number15
DOIs
Publication statusPublished - Apr 13 2008

Fingerprint

Chronic Renal Insufficiency
Chronic Kidney Failure
Stroke
Kidney
Cerebrovascular Disorders
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cerebral Hemorrhage
Acute Disease
Anticoagulants
Antihypertensive Agents
Aspirin
Cardiovascular Diseases
Therapeutics
Hypertension
Lipids
Research
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stroke krónikus veseelégtelenségben. / Bereczki, D.

In: Orvosi Hetilap, Vol. 149, No. 15, 13.04.2008, p. 691-696.

Research output: Contribution to journalArticle

Bereczki, D. / Stroke krónikus veseelégtelenségben. In: Orvosi Hetilap. 2008 ; Vol. 149, No. 15. pp. 691-696.
@article{c0203ffd0fe946a59a4b2f8f99c65d7e,
title = "Stroke kr{\'o}nikus veseel{\'e}gtelens{\'e}gben",
abstract = "Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.",
keywords = "Cerebrovascular disorders, Chronic kidney disease",
author = "D. Bereczki",
year = "2008",
month = "4",
day = "13",
doi = "10.1556/OH.2008.28292",
language = "Hungarian",
volume = "149",
pages = "691--696",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "15",

}

TY - JOUR

T1 - Stroke krónikus veseelégtelenségben

AU - Bereczki, D.

PY - 2008/4/13

Y1 - 2008/4/13

N2 - Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.

AB - Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.

KW - Cerebrovascular disorders

KW - Chronic kidney disease

UR - http://www.scopus.com/inward/record.url?scp=43149102248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43149102248&partnerID=8YFLogxK

U2 - 10.1556/OH.2008.28292

DO - 10.1556/OH.2008.28292

M3 - Article

VL - 149

SP - 691

EP - 696

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 15

ER -